Business ❯ Corporate Governance ❯ Investor Relations ❯ Securities

Fraudulent Practices

Law Firms Urge Corcept Investors To Seek Lead Role In Securities Case Before April 21

The suit claims the company hid FDA concerns about relacorilant’s trial evidence.

Baxter Investors Face Dec. 15 Deadline To Seek Lead Role In Securities Suit Over Novum IQ Pump

Investor Firms Press Baxter Securities Case Over Novum Pump as Dec. 15 Lead-Plaintiff Deadline Nears

Quanex Faces Securities Class Action Over Tyman Mexico Disclosures as Lead‑Plaintiff Deadline Nears